Investigation of Kidney Transplant Patients for Antibodies and T-cells After Herpes Virus Vaccination and Infection

Status: Active_not_recruiting
Location: See all (5) locations...
Study Type: Observational
SUMMARY

Kidney transplant recipients are at increased risk of infections, including Varicella-zoster virus (VZV) infections. Vaccination against VZV is routinely offered to all kidney transplant recipients and candidates in Denmark. In this exploratory observational study, the VZV specific immune response in kidney transplant candidates and recipients will be characterized at different time points in relation to transplantation, vaccination and infections. More knowledge on the immune reaction to transplantation, VZV vaccination and VZV infections may provide improved strategies for prevention and treatment of VZV infections in kidney transplant candidates and recipients.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Kidney transplant recipient transplanted after 2019-01-01 OR on the kidney transplant waitlist

• Has been offered Shingrix® vaccination

Locations
Other Locations
Denmark
Department of Nephrology, Aarhus University Hospital
Aarhus
Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet
Copenhagen
Department of Nephrology, Copehagen University Hospital - Rigshospitalet
Copenhagen
Department of Health Technology, Technical University of Denmark
Lyngby
Department of Nephrology, Odense University Hospital
Odense
Time Frame
Start Date: 2023-01-01
Completion Date: 2026-02-01
Participants
Target number of participants: 280
Treatments
Kidney transplant patients
Related Therapeutic Areas
Sponsors
Collaborators: Odense University Hospital, Technical University of Denmark, Aarhus University Hospital
Leads: Susanne Dam Nielsen, MD, DMSc

This content was sourced from clinicaltrials.gov